Teodora Kaltcheva

1.1k total citations
21 papers, 688 citations indexed

About

Teodora Kaltcheva is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Teodora Kaltcheva has authored 21 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Teodora Kaltcheva's work include Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (8 papers) and Immunotherapy and Immune Responses (6 papers). Teodora Kaltcheva is often cited by papers focused on Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (8 papers) and Immunotherapy and Immune Responses (6 papers). Teodora Kaltcheva collaborates with scholars based in United States, France and Germany. Teodora Kaltcheva's co-authors include Don J. Diamond, Edwin R. Manuel, Joshua D.I. Ellenhorn, Bruce R. Blazar, Corinna La Rosa, Weimin Tsai, Nicola Hardwick, Jeff Longmate, Joy Martinez and Ryotaro Nakamura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Teodora Kaltcheva

21 papers receiving 675 citations

Peers

Teodora Kaltcheva
Weimin Tsai United States
Jonas Söderholm Sweden
Lindvi Gudmundsdotter Sweden
Yanal Murad Canada
Petra B. van den Doel Netherlands
Reshma Singh United States
Mariana O. Diniz United Kingdom
Stephen Pacchione United States
Weixu Meng China
J Culp United States
Weimin Tsai United States
Teodora Kaltcheva
Citations per year, relative to Teodora Kaltcheva Teodora Kaltcheva (= 1×) peers Weimin Tsai

Countries citing papers authored by Teodora Kaltcheva

Since Specialization
Citations

This map shows the geographic impact of Teodora Kaltcheva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teodora Kaltcheva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teodora Kaltcheva more than expected).

Fields of papers citing papers by Teodora Kaltcheva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teodora Kaltcheva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teodora Kaltcheva. The network helps show where Teodora Kaltcheva may publish in the future.

Co-authorship network of co-authors of Teodora Kaltcheva

This figure shows the co-authorship network connecting the top 25 collaborators of Teodora Kaltcheva. A scholar is included among the top collaborators of Teodora Kaltcheva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teodora Kaltcheva. Teodora Kaltcheva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martinez, Joy, Angelina Iniguez, Mindy Kha, et al.. (2024). Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform. npj Vaccines. 9(1). 68–68. 2 indexed citations
2.
Rosa, Corinna La, Ibrahim Aldoss, Dongyun Yang, et al.. (2023). CMV-MVA Triplex Vaccination of Stem Cell Donors to Enhance CMV Specific Immunity and Prevent CMV Viremia in Recipients after Stem Cell Transplant. Transplantation and Cellular Therapy. 29(2). S68–S69. 1 indexed citations
3.
4.
Rosa, Corinna La, Flavia Chiuppesi, Alfredo Puing, et al.. (2022). Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity. Blood Advances. 6(6). 1645–1650. 3 indexed citations
5.
Chiuppesi, Flavia, Marcela D Salazar, Heidi Contreras, et al.. (2020). Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform. Nature Communications. 11(1). 6121–6121. 66 indexed citations
6.
Aldoss, Ibrahim, Corinna La Rosa, Lindsey R. Baden, et al.. (2020). Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients. Annals of Internal Medicine. 172(5). 306–316. 47 indexed citations
7.
Phan, Thuy, Vu H. Nguyen, Edwin R. Manuel, et al.. (2019). Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth. Cancer Gene Therapy. 27(3-4). 235–245. 55 indexed citations
8.
Hardwick, Nicola, Paul Frankel, Christopher Ruel, et al.. (2018). p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy. Clinical Cancer Research. 24(6). 1315–1325. 54 indexed citations
9.
Rosa, Corinna La, Jeff Longmate, Qiao Zhou, et al.. (2018). Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax. Biology of Blood and Marrow Transplantation. 25(4). 771–784. 10 indexed citations
10.
Chiuppesi, Flavia, Jenny Nguyen, Soojin Park, et al.. (2018). Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice. Journal of Virology. 92(19). 29 indexed citations
11.
Chiuppesi, Flavia, Teodora Kaltcheva, Meng Zhuo, et al.. (2017). Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus. Journal of Virology. 91(6). 10 indexed citations
12.
Rosa, Corinna La, Jeff Longmate, Joy Martinez, et al.. (2016). MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults. Blood. 129(1). 114–125. 58 indexed citations
13.
Manuel, Edwin R., Massimo D’Apuzzo, Teodora Kaltcheva, et al.. (2015). Salmonella -Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors. Cancer Immunology Research. 3(9). 1096–1107. 53 indexed citations
14.
Hardwick, Nicola, Mary Carroll, Teodora Kaltcheva, et al.. (2014). p53MVA Therapy in Patients with Refractory Gastrointestinal Malignancies Elevates p53-Specific CD8+ T-cell Responses. Clinical Cancer Research. 20(17). 4459–4470. 35 indexed citations
15.
Rosa, Corinna La, Weimin Tsai, Teodora Kaltcheva, et al.. (2013). Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms’ tumor antigen in patients with non-Hodgkin lymphoma. Leukemia & lymphoma. 54(11). 2490–2499. 4 indexed citations
16.
Manuel, Edwin R., et al.. (2012). Systemic Delivery of Salmonella typhimurium Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth. Cancer Research. 72(24). 6447–6456. 78 indexed citations
17.
Rosa, Corinna La, Jeff Longmate, Simon F. Lacey, et al.. (2012). Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant. The Journal of Infectious Diseases. 205(8). 1294–1304. 69 indexed citations
18.
Manuel, Edwin R., Teodora Kaltcheva, Hidenobu Ishizaki, et al.. (2011). Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-Targeting Salmonella- Based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors. Cancer Research. 71(12). 4183–4191. 70 indexed citations
19.
Lacey, Simon F., Corinna La Rosa, Teodora Kaltcheva, et al.. (2011). Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice. Blood. 118(8). 2159–2169. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weimin Tsai Breakdown of academic impact, for papers by Jonas Söderholm Breakdown of academic impact, for papers by Lindvi Gudmundsdotter Breakdown of academic impact, for papers by Yanal Murad Breakdown of academic impact, for papers by Petra B. van den Doel Breakdown of academic impact, for papers by Reshma Singh Breakdown of academic impact, for papers by Mariana O. Diniz Breakdown of academic impact, for papers by Stephen Pacchione Breakdown of academic impact, for papers by Weixu Meng Breakdown of academic impact, for papers by J Culp
Rankless by CCL
2026